Handelsavisen
prelaunch
MS
MSHGN.F Frankfurt Food Retail & Distribution

WASGAU Produktions & Handels AG

Open in Charts → Attach watcher ⌖
EUR
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,17 %
Op margin
1,7 %
ROE
2,1 %
Net margin
0,4 %
Debt / equity
2,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

MSHGN.F operates in the Food Retail & Distribution industry, generating revenue primarily through the sale of food and drug products to consumers.

Business. MSHGN.F is a food and drug retailing company listed on the Frankfurt Stock Exchange. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on the Food Retail & Distribution industry. It generates revenue through the sale of products, with key performance indicators including same-store sales growth, traffic, and average ticket size. Specific details regarding operating segments, headquarters location, and geographic mix are not available in the provided data.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Drug Retailing
IndustryFood Retail & Distribution
ActivityFood & Drug Retailing
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
2,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning MSHGN.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to MSHGN.F. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    MSHGN.F is a food and drug retailing company listed on the Frankfurt Stock Exchange. The firm operates within the Consumer Non-Cyclicals sector, specifically focusing on the Food Retail & Distribution industry. It generates revenue through the sale of products, with key performance indicators including same-store sales growth, traffic, and average ticket size. Specific details regarding operating segments, headquarters location, and geographic mix are not available in the provided data.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Drug Retailing
    IndustryFood Retail & Distribution
    ActivityFood & Drug Retailing
    AI synthesis
    GENERATED

    MSHGN.F has a debt-to-equity ratio of 2.0, indicating a capital structure that is significantly leveraged. The company's liquidity position is characterized as medium risk, with a current ratio of 1.31, suggesting it has sufficient short-term assets to cover its short-term liabilities, but not with a large margin of safety. The company's free cash flow of 14.91 million EUR indicates it is generating positive cash from operations after capital expenditures, but the amount is relatively modest compared to its total assets of 398.6 million EUR.

    Profitability metrics for MSHGN.F show a return on equity (ROE) of 2.09% and a return on assets (ROA) of 0.59%, both of which are below the typical thresholds for strong performance in the retail sector. The company's operating income of 11.14 million EUR and net income of 2.35 million EUR suggest that while it is profitable, its margins are thin, and it is not generating substantial returns relative to its asset base.

    The company's revenue is concentrated in the Food & Drug Retailing segment, with no disclosed geographic diversification in the provided data. This lack of geographic segmentation implies that the company's performance is closely tied to the local market, which could expose it to regional economic fluctuations and regulatory changes.

    Looking at the growth trajectory, MSHGN.F reported a revenue of 654.5 million EUR in the latest period, with an operating cash flow of 36.4 million EUR. While the company is generating positive cash flow, the absence of forward-looking guidance or analyst estimates for the next fiscal year makes it difficult to assess the sustainability of this growth.

    The risk assessment for MSHGN.F highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could limit its ability to fund operations or invest in growth opportunities without external financing. However, the low dilution risk suggests that the company is not currently issuing a significant number of new shares, which is a positive sign for existing shareholders.

    Recent events and filings for MSHGN.F are not detailed in the provided data, but the company's financial performance and risk profile suggest that it is operating in a competitive and capital-intensive industry. The company's ability to maintain or improve its profitability and liquidity will be critical to its long-term success.

    Key takeaways
    • MSHGN.F has a high debt-to-equity ratio of 2.0, indicating a leveraged capital structure.
    • The company's ROE of 2.09% and ROA of 0.59% are below typical performance benchmarks in the retail sector.
    • MSHGN.F's revenue is concentrated in the Food & Drug Retailing segment, with no geographic diversification disclosed.
    • The company's liquidity position is characterized as medium risk, with a current ratio of 1.31.
    • MSHGN.F has a low dilution risk, suggesting it is not currently issuing a significant number of new shares.
    • The company's net cash position is negative after accounting for total debt, which could limit its ability to fund operations or invest in growth opportunities without external financing.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    €112.4M
    Net cash
    -€203.2M
    Current ratio
    1.3
    Debt / equity
    2.0
    ROA
    0.6%
    ROE
    2.1%
    Cash conversion
    1546.0%
    CapEx / revenue
    -3.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin1,7 %Below median
    Net Margin0,4 %Below median
    ROE2,1 %Below median
    Capex / Rev-3,8 %Below median
    D/E2,00Bottom quartile
    Cash Conv15,46Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • MSHGN.F Market data — financials · 2026-05-28
    • WASGAU Produktions & Handels AG Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Leadership

    • Christian MielschChairman of the Supervisory Board
    • Thomas BingsMember of the Management Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    MSHGN.FCanonical
    Frankfurt · EUR

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage